ursolic acid has been researched along with Pulmonary Disease, Chronic Obstructive in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Chen, J; Li, C; Tan, H; Yuan, W; Zhang, W | 1 |
| Han, D; Hou, G; Kang, J; Lin, L; Wang, Q; Yin, Y | 1 |
2 other study(ies) available for ursolic acid and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Preventive effect of ursolic acid derivative on particulate matter 2.5-induced chronic obstructive pulmonary disease involves suppression of lung inflammation.
Topics: Animals; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Male; Mice; Oxidative Stress; Particulate Matter; Pneumonia; Protective Agents; Pulmonary Disease, Chronic Obstructive; Triterpenes; Ursolic Acid | 2020 |
Ursolic acid attenuates cigarette smoke-induced emphysema in rats by regulating PERK and Nrf2 pathways.
Topics: Animals; Antioxidants; Apoptosis; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Down-Regulation; eIF-2 Kinase; Lung; Male; NF-E2-Related Factor 2; Nicotiana; Oxidative Stress; Pulmonary Alveoli; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Rats; Rats, Wistar; Smoke; Smoking; Triterpenes; Up-Regulation; Ursolic Acid | 2017 |